{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:08:24Z","timestamp":1791284904725,"version":"4.1.0"},"reference-count":298,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11154-025-09996-z","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:22:00Z","timestamp":1761200520000},"page":"69-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-1300","authenticated-orcid":false,"given":"Pedro","family":"Carrera-Bastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-555X","authenticated-orcid":false,"given":"Marcel H. A.","family":"Muskiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4126-577X","authenticated-orcid":false,"given":"Fernando","family":"Mata-Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-4675","authenticated-orcid":false,"given":"Leo","family":"Pruimboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-0997","authenticated-orcid":false,"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-1913","authenticated-orcid":false,"given":"Raul M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7765-9423","authenticated-orcid":false,"given":"Frits A. J.","family":"Muskiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"9996_CR1","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s42255-023-00927-3","volume":"5","author":"CB Thompson","year":"2023","unstructured":"Thompson CB, Vousden KH, Johnson RS, Koppenol WH, Sies H, Lu Z, et al. A century of the Warburg effect. Nat Metab. 2023;5:1840\u20133.","journal-title":"Nat Metab"},{"key":"9996_CR2","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"S-M Fendt","year":"2024","unstructured":"Fendt S-M. 100 years of the Warburg effect: a cancer metabolism endeavor. Cell. 2024;187:3824\u20138.","journal-title":"Cell"},{"key":"9996_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41:211\u20138.","journal-title":"Trends Biochem Sci"},{"key":"9996_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","volume":"33","author":"Y Wang","year":"2023","unstructured":"Wang Y, Patti GJ. The warburg effect: a signature of mitochondrial overload. Trends Cell Biol. 2023;33:1014\u201320.","journal-title":"Trends Cell Biol"},{"key":"9996_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"9996_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00279","volume":"8","author":"AM Abdel-Haleem","year":"2017","unstructured":"Abdel-Haleem AM, Lewis NE, Jamshidi N, Mineta K, Gao X, Gojobori T. The emerging facets of non-cancerous Warburg effect. Front Endocrinol (Lausanne). 2017;8:279.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9996_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.gpb.2018.12.006","volume":"17","author":"H Sun","year":"2019","unstructured":"Sun H, Chen L, Cao S, Liang Y, Xu Y. Warburg effects in cancer and normal proliferating cells: two tales of the same name. Genomics Proteomics Bioinformatics. 2019;17:273\u201386.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"9996_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis RJ, Chandel NS. We need to talk about the Warburg effect. Nat Metab. 2020;2:127\u20139.","journal-title":"Nat Metab"},{"key":"9996_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells. 2021;10:1056.","journal-title":"Cells"},{"key":"9996_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41467-020-15136-9","volume":"11","author":"M Kodama","year":"2020","unstructured":"Kodama M, Oshikawa K, Shimizu H, Yoshioka S, Takahashi M, Izumi Y, et al. A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer. Nat Commun. 2020;11:1320.","journal-title":"Nat Commun"},{"key":"9996_CR11","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021;599:1745\u201357.","journal-title":"J Physiol"},{"key":"9996_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3389\/fonc.2020.01561","volume":"10","author":"ES Birkeland","year":"2020","unstructured":"Birkeland ES, Koch LM, Dechant R. Another consequence of the Warburg effect? Metabolic regulation of Na+\/H+ exchangers may link aerobic glycolysis to cell growth. Front Oncol. 2020;10:1561.","journal-title":"Front Oncol"},{"key":"9996_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153694","volume":"20","author":"RA Cardone","year":"2019","unstructured":"Cardone RA, Alfarouk KO, Elliott RL, Alqahtani SS, Ahmed SBM, Aljarbou AN, et al. The role of sodium hydrogen exchanger 1 in dysregulation of proton dynamics and reprogramming of cancer metabolism as a sequela. Int J Mol Sci. 2019;20:3694.","journal-title":"Int J Mol Sci"},{"key":"9996_CR14","volume":"1872","author":"TK Leslie","year":"2019","unstructured":"Leslie TK, James AD, Zaccagna F, Grist JT, Deen S, Kennerley A, et al. Sodium homeostasis in the tumour microenvironment. Biochimica et Biophysica Acta (BBA). 2019;1872:188304.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"9996_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108690","volume":"112","author":"Z Ghanbari Movahed","year":"2019","unstructured":"Ghanbari Movahed Z, Rastegari-Pouyani M, Mohammadi MH, Mansouri K. Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell? Biomed Pharmacother. 2019;112:108690.","journal-title":"Biomed Pharmacother"},{"key":"9996_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","volume":"356","author":"J Lu","year":"2015","unstructured":"Lu J, Tan M, Cai Q. The warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356:156\u201364.","journal-title":"Cancer Lett"},{"key":"9996_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9996_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20:436\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9996_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00958","volume":"8","author":"C Corbet","year":"2017","unstructured":"Corbet C. Stem cell metabolism in cancer and healthy tissues: pyruvate in the limelight. Front Pharmacol. 2017;8:958.","journal-title":"Front Pharmacol"},{"key":"9996_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354.","journal-title":"Nat Cell Biol"},{"key":"9996_CR21","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-024-01402-6","volume":"31","author":"L Lanzetti","year":"2024","unstructured":"Lanzetti L. Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer. Cell Death Differ. 2024;31:1582\u201394.","journal-title":"Cell Death Differ"},{"key":"9996_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun J-K, Choi Y-K, Park K-G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55:706\u201315.","journal-title":"Exp Mol Med"},{"key":"9996_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/OTT.S397593","volume":"16","author":"SM El Sayed","year":"2023","unstructured":"El Sayed SM. Biochemical origin of the Warburg effect in light of 15 years of research experience: a novel evidence-based view (an expert opinion article). Onco Targets Ther. 2023;16:143\u201355.","journal-title":"Onco Targets Ther"},{"key":"9996_CR24","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.3390\/ijms242115787","volume":"24","author":"L Alberghina","year":"2023","unstructured":"Alberghina L. The Warburg effect explained: integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation. IJMS. 2023;24:15787.","journal-title":"IJMS"},{"key":"9996_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00109-015-1307-x","volume":"94","author":"I Marchiq","year":"2016","unstructured":"Marchiq I, Pouyss\u00e9gur J. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate\/H(+) symporters. J Mol Med (Berl). 2016;94:155\u201371.","journal-title":"J Mol Med (Berl)"},{"key":"9996_CR26","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1016\/j.bbamcr.2016.01.017","volume":"1863","author":"T Bender","year":"2016","unstructured":"Bender T, Martinou J-C. The mitochondrial pyruvate carrier in health and disease: to carry or not to carry? Biochim Biophys Acta. 2016;1863:2436\u201342.","journal-title":"Biochim Biophys Acta"},{"key":"9996_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"9996_CR28","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","volume":"292","author":"SA Mookerjee","year":"2017","unstructured":"Mookerjee SA, Gerencser AA, Nicholls DG, Brand MD. Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J Biol Chem. 2017;292:7189\u2013207.","journal-title":"J Biol Chem"},{"key":"9996_CR29","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s42255-020-00276-5","volume":"2","author":"M Fernandez-Caggiano","year":"2020","unstructured":"Fernandez-Caggiano M, Kamynina A, Francois AA, Prysyazhna O, Eykyn TR, Krasemann S, et al. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. Nat Metab. 2020;2:1223\u201331.","journal-title":"Nat Metab"},{"key":"9996_CR30","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/s42255-023-00935-3","volume":"5","author":"AB Nelson","year":"2023","unstructured":"Nelson AB, Queathem ED, Puchalska P, Crawford PA. Metabolic messengers: ketone bodies. Nat Metab. 2023;5:2062\u201374.","journal-title":"Nat Metab"},{"key":"9996_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"9996_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020996","volume":"23","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto T, Sano M. Deranged myocardial fatty acid metabolism in heart failure. Int J Mol Sci. 2022;23:996.","journal-title":"Int J Mol Sci"},{"key":"9996_CR33","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.255802","volume":"135","author":"E Almacellas","year":"2022","unstructured":"Almacellas E, Mauvezin C. Emerging roles of mitotic autophagy. J Cell Sci. 2022;135:jcs255802.","journal-title":"J Cell Sci"},{"key":"9996_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083972","volume":"22","author":"L Schwartz","year":"2021","unstructured":"Schwartz L, Henry M, Alfarouk KO, Reshkin SJ, Radman M. Metabolic shifts as the hallmark of most common diseases: the quest for the underlying unity. Int J Mol Sci. 2021;22:3972.","journal-title":"Int J Mol Sci"},{"key":"9996_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00042","volume":"9","author":"W Eisenreich","year":"2019","unstructured":"Eisenreich W, Rudel T, Heesemann J, Goebel W. How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication. Front Cell Infect Microbiol. 2019;9:42.","journal-title":"Front Cell Infect Microbiol"},{"key":"9996_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122755","volume":"18","author":"JS Burns","year":"2017","unstructured":"Burns JS, Manda G. Metabolic pathways of the Warburg effect in health and disease: perspectives of choice, chain or chance. Int J Mol Sci. 2017;18:2755.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"9996_CR37","volume":"10","author":"F Bouillaud","year":"2021","unstructured":"Bouillaud F, Hammad N, Schwartz L. Warburg effect, glutamine, succinate, alanine, when oxygen matters. Biology (Basel). 2021;10(10):1000.","journal-title":"Biology (Basel)"},{"key":"9996_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1486","volume":"12","author":"MD Kornberg","year":"2020","unstructured":"Kornberg MD. The immunologic Warburg effect: evidence and therapeutic opportunities in autoimmunity. Wiley Interdiscip Rev Syst Biol Med. 2020;12:e1486.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"9996_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/bies.201300084","volume":"35","author":"EM Palsson-McDermott","year":"2013","unstructured":"Palsson-McDermott EM, O\u2019Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays. 2013;35:965\u201373.","journal-title":"BioEssays"},{"key":"9996_CR40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tibs.2018.12.007","volume":"44","author":"P Icard","year":"2019","unstructured":"Icard P, Fournel L, Wu Z, Alifano M, Lincet H. Interconnection between metabolism and cell cycle in cancer. Trends Biochem Sci. 2019;44:490\u2013501.","journal-title":"Trends Biochem Sci"},{"key":"9996_CR41","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1002\/jcp.25998","volume":"233","author":"Z Chen","year":"2018","unstructured":"Chen Z, Liu M, Li L, Chen L. Involvement of the warburg effect in non-tumor diseases processes. J Cell Physiol. 2018;233:2839\u201349.","journal-title":"J Cell Physiol"},{"key":"9996_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.semnephrol.2018.01.002","volume":"38","author":"G Zhang","year":"2018","unstructured":"Zhang G, Darshi M, Sharma K. The Warburg effect in diabetic kidney disease. Semin Nephrol. 2018;38:111\u201320.","journal-title":"Semin Nephrol"},{"key":"9996_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063062","volume":"22","author":"H Kaneto","year":"2021","unstructured":"Kaneto H, Obata A, Kimura T, Shimoda M, Kinoshita T, Matsuoka T-A, et al. Unexpected pleiotropic effects of SGLT2 inhibitors: pearls and pitfalls of this novel antidiabetic class. Int J Mol Sci. 2021;22:3062.","journal-title":"Int J Mol Sci"},{"key":"9996_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-8587(20)30428-9","volume":"9","author":"MHA Muskiet","year":"2021","unstructured":"Muskiet MHA, Heerspink HJL, van Raalte DH. SGLT2 inhibitors: expanding their empire beyond diabetes. Lancet Diabetes Endocrinol. 2021;9:59\u201361.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9996_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073651","volume":"23","author":"T Salvatore","year":"2022","unstructured":"Salvatore T, Galiero R, Caturano A, Rinaldi L, Di Martino A, Albanese G, et al. An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors. Int J Mol Sci. 2022;23:3651.","journal-title":"Int J Mol Sci"},{"key":"9996_CR46","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.124.069568","volume":"149","author":"SM Patel","year":"2024","unstructured":"Patel SM, Kang YM, Im K, Neuen BL, Anker SD, Bhatt DL, et al. Sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes: a SMART-C collaborative meta-analysis. Circulation. 2024;149:1789\u2013801.","journal-title":"Circulation"},{"key":"9996_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","volume":"12","author":"MS Usman","year":"2024","unstructured":"Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, et al. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2024;12:447\u201361.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9996_CR48","first-page":"CD015588","volume":"5","author":"P Natale","year":"2024","unstructured":"Natale P, Tunnicliffe DJ, Toyama T, Palmer SC, Saglimbene VM, Ruospo M, et al. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2024;5:CD015588.","journal-title":"Cochrane Database Syst Rev."},{"key":"9996_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031805","volume":"13","author":"R Kani","year":"2024","unstructured":"Kani R, Watanabe A, Miyamoto Y, Ejiri K, Iwagami M, Takagi H, et al. Comparison of effectiveness among different sodium-glucose cotransoporter-2 inhibitors according to underlying conditions: a network meta-analysis of randomized controlled trials. JAHA. 2024;13:e031805.","journal-title":"JAHA"},{"key":"9996_CR50","doi-asserted-by":"publisher","first-page":"e019463","DOI":"10.1161\/JAHA.120.019463","volume":"10","author":"YH Teo","year":"2021","unstructured":"Teo YH, Teo YN, Syn NL, Kow CS, Yoong CSY, Tan BYQ, et al. Effects of sodium\/glucose cotransporter 2 (SGLT2) inhibitors on cardiovascular and metabolic outcomes in patients without diabetes mellitus: a systematic review and meta-analysis of randomized-controlled trials. JAHA. 2021;10:e019463.","journal-title":"JAHA"},{"key":"9996_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01480-1","volume":"21","author":"S Chen","year":"2022","unstructured":"Chen S, Coronel R, Hollmann MW, Weber NC, Zuurbier CJ. Direct cardiac effects of SGLT2 inhibitors. Cardiovasc Diabetol. 2022;21:45.","journal-title":"Cardiovasc Diabetol"},{"key":"9996_CR52","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","volume":"146","author":"M Packer","year":"2022","unstructured":"Packer M. Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis. Circulation. 2022;146:1383\u2013405.","journal-title":"Circulation"},{"key":"9996_CR53","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ijcard.2017.03.089","volume":"241","author":"P Perrone-Filardi","year":"2017","unstructured":"Perrone-Filardi P, Avogaro A, Bonora E, Colivicchi F, Fioretto P, Maggioni AP, et al. Mechanisms linking empagliflozin to cardiovascular and renal protection. Int J Cardiol. 2017;241:450\u20136.","journal-title":"Int J Cardiol"},{"key":"9996_CR54","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2174\/15701611113116660149","volume":"12","author":"M Burke","year":"2014","unstructured":"Burke M, Pabbidi MR, Farley J, Roman RJ. Molecular mechanisms of renal blood flow autoregulation. Curr Vasc Pharmacol. 2014;12:845\u201358.","journal-title":"Curr Vasc Pharmacol"},{"key":"9996_CR55","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","volume":"140","author":"K Kidokoro","year":"2019","unstructured":"Kidokoro K, Cherney DZI, Bozovic A, Nagasu H, Satoh M, Kanda E, et al. Evaluation of glomerular hemodynamic function by Empagliflozin in diabetic mice using in vivo imaging. Circulation. 2019;140:303\u201315.","journal-title":"Circulation"},{"key":"9996_CR56","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cmet.2021.02.016","volume":"33","author":"T Sen","year":"2021","unstructured":"Sen T, Heerspink HJL. A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors. Cell Metab. 2021;33:732\u20139.","journal-title":"Cell Metab"},{"key":"9996_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","volume":"22","author":"CJ Bailey","year":"2022","unstructured":"Bailey CJ, Day C, Bellary S. Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease. Curr Diab Rep. 2022;22:39\u201352.","journal-title":"Curr Diab Rep"},{"key":"9996_CR58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167700","volume":"133","author":"KR Tuttle","year":"2023","unstructured":"Tuttle KR. Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors. J Clin Invest. 2023;133:e167700.","journal-title":"J Clin Invest"},{"key":"9996_CR59","doi-asserted-by":"publisher","first-page":"C243","DOI":"10.1152\/ajpcell.00147.2023","volume":"325","author":"B Lee","year":"2023","unstructured":"Lee B, Holstein-Rathlou N-H, Sosnovtseva O, S\u00f8rensen CM. Renoprotective effects of GLP-1 receptor agonists and SGLT-2 inhibitors\u2014is hemodynamics the key point? Am J Physiol-Cell Physiol. 2023;325:C243\u201356.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"9996_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.123.064346","volume":"148","author":"M Packer","year":"2023","unstructured":"Packer M, Wilcox CS, Testani JM. Critical analysis of the effects of SGLT2 inhibitors on renal tubular sodium, water and chloride homeostasis and their role in influencing heart failure outcomes. Circulation. 2023;148:354\u201372.","journal-title":"Circulation"},{"key":"9996_CR61","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00424-020-02361-w","volume":"472","author":"V Vallon","year":"2020","unstructured":"Vallon V. Glucose transporters in the kidney in health and disease. Pflugers Arch - Eur J Physiol. 2020;472:1345\u201370.","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"9996_CR62","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2010.509","volume":"79","author":"A Mather","year":"2011","unstructured":"Mather A, Pollock C. Glucose handling by the kidney. Kidney Int. 2011;79:S1-6.","journal-title":"Kidney Int"},{"key":"9996_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon V, Thomson SC. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020;16:317\u201336.","journal-title":"Nat Rev Nephrol"},{"key":"9996_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","volume":"60","author":"V Vallon","year":"2017","unstructured":"Vallon V, Thomson SC. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia. 2017;60:215\u201325.","journal-title":"Diabetologia"},{"key":"9996_CR65","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28:1023\u201339.","journal-title":"J Am Soc Nephrol"},{"key":"9996_CR66","doi-asserted-by":"publisher","first-page":"F889","DOI":"10.1152\/ajprenal.00267.2015","volume":"309","author":"MA Abdul-Ghani","year":"2015","unstructured":"Abdul-Ghani MA, Norton L, DeFronzo RA. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus. Am J Physiol Renal Physiol. 2015;309:F889-900.","journal-title":"Am J Physiol Renal Physiol"},{"key":"9996_CR67","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/dom.13224","volume":"20","author":"D Polidori","year":"2018","unstructured":"Polidori D, Iijima H, Goda M, Maruyama N, Inagaki N, Crawford PA. Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin. Diabetes Obes Metab. 2018;20:1321\u20136.","journal-title":"Diabetes Obes Metab"},{"key":"9996_CR68","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2337\/dc21-2043","volume":"45","author":"RA Herring","year":"2022","unstructured":"Herring RA, Shojaee-Moradie F, Stevenage M, Parsons I, Jackson N, Mendis J, et al. The SGLT2 inhibitor dapagliflozin increases the oxidation of ingested fatty acids to ketones in type 2 diabetes. Diabetes Care. 2022;45:1408\u201315.","journal-title":"Diabetes Care"},{"key":"9996_CR69","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dci19-0074","volume":"43","author":"M Packer","year":"2020","unstructured":"Packer M. SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action. Diabetes Care. 2020;43:508\u201311.","journal-title":"Diabetes Care"},{"key":"9996_CR70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4147","volume":"371","author":"G Musso","year":"2020","unstructured":"Musso G, Saba F, Cassader M, Gambino R. Diabetic ketoacidosis with SGLT2 inhibitors. BMJ. 2020;371:m4147.","journal-title":"BMJ"},{"key":"9996_CR71","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1113\/JP273185","volume":"595","author":"M Evans","year":"2017","unstructured":"Evans M, Cogan KE, Egan B. Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation. J Physiol. 2017;595:2857\u201371.","journal-title":"J Physiol"},{"key":"9996_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228767","volume":"21","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Wodschow HZ, Nilsson M, Rungby J. Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases. Int J Mol Sci. 2020;21:8767.","journal-title":"Int J Mol Sci"},{"key":"9996_CR73","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","volume":"132","author":"TR Matsuura","year":"2023","unstructured":"Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the heart: metabolic principles and therapeutic implications. Circ Res. 2023;132:882\u201398.","journal-title":"Circ Res"},{"key":"9996_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.arres.2021.100009","volume":"2","author":"P Rojas-Morales","year":"2021","unstructured":"Rojas-Morales P, Pedraza-Chaverri J, Tapia E. Ketone bodies for kidney injury and disease. Adv Redox Res. 2021;2:100009.","journal-title":"Adv Redox Res"},{"key":"9996_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02185-0","volume":"19","author":"H Kolb","year":"2021","unstructured":"Kolb H, Kempf K, R\u00f6hling M, Lenzen-Schulte M, Schloot NC, Martin S. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 2021;19:313.","journal-title":"BMC Med"},{"key":"9996_CR76","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-111120-111518","volume":"41","author":"P Puchalska","year":"2021","unstructured":"Puchalska P, Crawford PA. Metabolic and signaling roles of ketone bodies in health and disease. Annu Rev Nutr. 2021;41:49\u201377.","journal-title":"Annu Rev Nutr"},{"key":"9996_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12999","volume":"1367","author":"SC Cunnane","year":"2016","unstructured":"Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, et al. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer\u2019s disease. Ann N Y Acad Sci. 2016;1367:12\u201320.","journal-title":"Ann N Y Acad Sci"},{"key":"9996_CR78","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2337\/dc16-0542","volume":"39","author":"S Mudaliar","year":"2016","unstructured":"Mudaliar S, Alloju S, Henry RR. Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis. Diabetes Care. 2016;39:1115\u201322.","journal-title":"Diabetes Care"},{"key":"9996_CR79","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/dc16-0330","volume":"39","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini E, Mark M, Mayoux E. CV Protection in the EMPA-REG OUTCOME Trial: A \u201cThrifty Substrate\u201d Hypothesis. Diabetes Care. 2016;39:1108\u201314.","journal-title":"Diabetes Care"},{"key":"9996_CR80","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","volume":"73","author":"CG Santos-Gallego","year":"2019","unstructured":"Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, et al. Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics. J Am Coll Cardiol. 2019;73:1931\u201344.","journal-title":"J Am Coll Cardiol"},{"key":"9996_CR81","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.122.060402","volume":"146","author":"S Selvaraj","year":"2022","unstructured":"Selvaraj S, Fu Z, Jones P, Kwee LC, Windsor SL, Ilkayeva O, et al. Metabolomic profiling of the effects of Dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HF. Circulation. 2022;146:808\u201318.","journal-title":"Circulation"},{"key":"9996_CR82","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.122.060805","volume":"146","author":"CG Santos-Gallego","year":"2022","unstructured":"Santos-Gallego CG, Mayr M, Badimon J. SGLT2 inhibitors in heart failure: targeted metabolomics and energetic metabolism. Circulation. 2022;146:819\u201321.","journal-title":"Circulation"},{"key":"9996_CR83","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","volume":"9","author":"JA Requena-Ib\u00e1\u00f1ez","year":"2021","unstructured":"Requena-Ib\u00e1\u00f1ez JA, Santos-Gallego CG, Rodriguez-Cordero A, Vargas-Delgado AP, Mancini D, Sartori S, et al. Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: From the EMPA-TROPISM study. JACC Heart Fail. 2021;9:578\u201389.","journal-title":"JACC Heart Fail"},{"key":"9996_CR84","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen R, M\u00f8ller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, et al. Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation. 2019;139:2129\u201341.","journal-title":"Circulation"},{"key":"9996_CR85","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jchf.2023.05.029","volume":"11","author":"K Berg-Hansen","year":"2023","unstructured":"Berg-Hansen K, Christensen KH, Gopalasingam N, Nielsen R, Eiskj\u00e6r H, M\u00f8ller N, et al. Beneficial effects of ketone ester in patients with cardiogenic shock: a randomized, controlled. Double-Blind Trial JACC Heart Fail. 2023;11:1337\u201347.","journal-title":"Double-Blind Trial JACC Heart Fail"},{"key":"9996_CR86","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.123.015298","volume":"16","author":"CG Santos-Gallego","year":"2023","unstructured":"Santos-Gallego CG, Requena-Ib\u00e1\u00f1ez JA, Picatoste B, Fardman B, Ishikawa K, Mazurek R, et al. Cardioprotective effect of Empagliflozin and circulating ketone bodies during acute myocardial infarction. Circ Cardiovasc Imaging. 2023;16:e015298.","journal-title":"Circ Cardiovasc Imaging"},{"key":"9996_CR87","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.diabet.2020.06.005","volume":"46","author":"M Morita","year":"2020","unstructured":"Morita M, Kanasaki K. Sodium-glucose cotransporter-2 inhibitors for diabetic kidney disease: targeting Warburg effects in proximal tubular cells. Diabetes Metab. 2020;46:353\u201361.","journal-title":"Diabetes Metab"},{"key":"9996_CR88","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/cells11040704","volume":"11","author":"R Uzbekov","year":"2022","unstructured":"Uzbekov R, Prigent C. A journey through time on the discovery of cell cycle regulation. Cells. 2022;11:704.","journal-title":"Cells"},{"key":"9996_CR89","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1038\/s41467-022-30545-8","volume":"13","author":"A Riba","year":"2022","unstructured":"Riba A, Oravecz A, Durik M, Jim\u00e9nez S, Alunni V, Cerciat M, et al. Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning. Nat Commun. 2022;13:2865.","journal-title":"Nat Commun"},{"key":"9996_CR90","volume-title":"The cell: a molecular approach","author":"GM Cooper","year":"2023","unstructured":"Cooper GM, Adams KW. The cell: a molecular approach. 9th ed. New York, NY: Oxford University Press; 2023.","edition":"9"},{"key":"9996_CR91","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","volume":"40","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S. The functional roles of TCA cycle metabolites in cancer. Oncogene. 2021;40:3351\u201363.","journal-title":"Oncogene"},{"key":"9996_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102838","volume":"299","author":"PK Arnold","year":"2023","unstructured":"Arnold PK, Finley LWS. Regulation and function of the mammalian tricarboxylic acid cycle. J Biol Chem. 2023;299:102838.","journal-title":"J Biol Chem"},{"key":"9996_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102.","journal-title":"Nat Commun"},{"key":"9996_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071488","volume":"13","author":"A Ruiz-Iglesias","year":"2021","unstructured":"Ruiz-Iglesias A, Ma\u00f1es S. The importance of mitochondrial pyruvate carrier in cancer cell metabolism and tumorigenesis. Cancers (Basel). 2021;13:1488.","journal-title":"Cancers (Basel)"},{"key":"9996_CR95","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1152\/japplphysiol.00497.2022","volume":"134","author":"GA Brooks","year":"2023","unstructured":"Brooks GA, Osmond AD, Arevalo JA, Duong JJ, Curl CC, Moreno-Santillan DD, et al. Lactate as a myokine and exerkine: drivers and signals of physiology and metabolism. J Appl Physiol. 2023;134:529\u201348.","journal-title":"J Appl Physiol"},{"key":"9996_CR96","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Peng Q, Zheng J, Yang Y, Zhang X, Ma A, et al. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment. Genes Dis. 2023;10:2029\u201337.","journal-title":"Genes Dis"},{"key":"9996_CR97","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cels.2019.01.005","volume":"8","author":"JC Patterson","year":"2019","unstructured":"Patterson JC, Joughin BA, Van De Kooij B, Lim DC, Lauffenburger DA, Yaffe MB. ROS and oxidative stress are elevated in mitosis during asynchronous cell cycle progression and are exacerbated by mitotic arrest. Cell Syst. 2019;8:163-167.e2.","journal-title":"Cell Syst"},{"key":"9996_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000519784","volume":"66","author":"N Ghanem","year":"2021","unstructured":"Ghanem N, El-Baba C, Araji K, El-Khoury R, Usta J, Darwiche N. The pentose phosphate pathway in cancer: regulation and therapeutic opportunities. Chemotherapy. 2021;66:179\u201391.","journal-title":"Chemotherapy"},{"key":"9996_CR99","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/nep.13578","volume":"24","author":"DM Rojas-Canales","year":"2019","unstructured":"Rojas-Canales DM, Li JY, Makuei L, Gleadle JM. Compensatory renal hypertrophy following nephrectomy: when and how? Nephrology. 2019;24:1225\u201332.","journal-title":"Nephrology"},{"key":"9996_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071658","volume":"9","author":"KW Jorgenson","year":"2020","unstructured":"Jorgenson KW, Phillips SM, Hornberger TA. Identifying the structural adaptations that drive the mechanical load-induced growth of skeletal muscle: a scoping review. Cells. 2020;9:1658.","journal-title":"Cells"},{"key":"9996_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.854998","volume":"10","author":"AM Lavecchia","year":"2022","unstructured":"Lavecchia AM, Pelekanos K, Mavelli F, Xinaris C. Cell hypertrophy: a \u201cbiophysical roadblock\u201d to reversing kidney injury. Front Cell Dev Biol. 2022;10:854998.","journal-title":"Front Cell Dev Biol"},{"key":"9996_CR102","unstructured":"Valenzuela PL, Carrera-Bastos P, Castillo-Garc\u00eda A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol [Internet]. 2023 [cited 2023 Mar 17]; Available from: https:\/\/www.nature.com\/articles\/s41569-023-00847-5"},{"key":"9996_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Sig Transduct Target Ther. 2023;8:152.","journal-title":"Sig Transduct Target Ther"},{"key":"9996_CR104","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"9996_CR105","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"9996_CR106","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.kint.2017.02.036","volume":"92","author":"R Schmitt","year":"2017","unstructured":"Schmitt R, Melk A. Molecular mechanisms of renal aging. Kidney Int. 2017;92:569\u201379.","journal-title":"Kidney Int"},{"key":"9996_CR107","doi-asserted-by":"publisher","first-page":"797025","DOI":"10.3389\/fendo.2021.797025","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liang W, Luo Q, Hu H, Yang K, Hu J, et al. PFKP activation ameliorates foot process fusion in podocytes in diabetic kidney disease. Front Endocrinol (Lausanne). 2021;12:797025.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9996_CR108","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1046\/j.1523-1755.2000.07710.x","volume":"77","author":"G Wolf","year":"2000","unstructured":"Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl. 2000;77:S59-66.","journal-title":"Kidney Int Suppl"},{"key":"9996_CR109","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.biopha.2018.02.105","volume":"101","author":"G-J Shi","year":"2018","unstructured":"Shi G-J, Shi G-R, Zhou J, Zhang W, Gao C, Jiang Y, et al. Involvement of growth factors in diabetes mellitus and its complications: a general review. Biomed Pharmacother. 2018;101:510\u201327.","journal-title":"Biomed Pharmacother"},{"key":"9996_CR110","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","volume":"46","author":"C-Y Jung","year":"2022","unstructured":"Jung C-Y, Yoo T-H. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J. 2022;46:181\u201397.","journal-title":"Diabetes Metab J"},{"key":"9996_CR111","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12933-023-01916-2","volume":"22","author":"R Mohebi","year":"2023","unstructured":"Mohebi R, Liu Y, Hansen MK, Yavin Y, Sattar N, Pollock CA, et al. Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial. Cardiovasc Diabetol. 2023;22:176.","journal-title":"Cardiovasc Diabetol"},{"key":"9996_CR112","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41598-022-04880-1","volume":"12","author":"N Uehara-Watanabe","year":"2022","unstructured":"Uehara-Watanabe N, Okuno-Ozeki N, Minamida A, Nakamura I, Nakata T, Nakai K, et al. Direct evidence of proximal tubular proliferation in early diabetic nephropathy. Sci Rep. 2022;12:778.","journal-title":"Sci Rep"},{"key":"9996_CR113","doi-asserted-by":"publisher","first-page":"1020443","DOI":"10.3389\/fphys.2022.1020443","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H, Feng J, Tang L. Early renal structural changes and potential biomarkers in diabetic nephropathy. Front Physiol. 2022;13:1020443.","journal-title":"Front Physiol"},{"key":"9996_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.929118","volume":"13","author":"PM Bertelli","year":"2022","unstructured":"Bertelli PM, Pedrini E, Hughes D, McDonnell S, Pathak V, Peixoto E, et al. Long term high glucose exposure induces premature senescence in retinal endothelial cells. Front Physiol. 2022;13:929118.","journal-title":"Front Physiol"},{"key":"9996_CR115","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13041-022-00947-2","volume":"15","author":"W-J Xue","year":"2022","unstructured":"Xue W-J, He C-F, Zhou R-Y, Xu X-D, Xiang L-X, Wang J-T, et al. High glucose and palmitic acid induces neuronal senescence by NRSF\/REST elevation and the subsequent mTOR-related autophagy suppression. Mol Brain. 2022;15:61.","journal-title":"Mol Brain"},{"key":"9996_CR116","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ceb.2019.05.005","volume":"60","author":"LR Pack","year":"2019","unstructured":"Pack LR, Daigh LH, Meyer T. Putting the brakes on the cell cycle: mechanisms of cellular growth arrest. Curr Opin Cell Biol. 2019;60:106\u201313.","journal-title":"Curr Opin Cell Biol"},{"key":"9996_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01523","volume":"10","author":"J Sabbatinelli","year":"2019","unstructured":"Sabbatinelli J, Prattichizzo F, Olivieri F, Procopio AD, Rippo MR, Giuliani A. Where metabolism meets senescence: focus on endothelial cells. Front Physiol. 2019;10:1523.","journal-title":"Front Physiol"},{"key":"9996_CR118","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer \u2014 role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"9996_CR119","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813\u201327.","journal-title":"Cell"},{"key":"9996_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari R, Jat P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. 2021;9:645593.","journal-title":"Front Cell Dev Biol"},{"key":"9996_CR121","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol. 2022;18:611\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"9996_CR122","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41420-024-01831-9","volume":"10","author":"J Chen","year":"2024","unstructured":"Chen J, Zhang H, Yi X, Dou Q, Yang X, He Y, et al. Cellular senescence of renal tubular epithelial cells in acute kidney injury. Cell Death Discov. 2024;10:62.","journal-title":"Cell Death Discov"},{"key":"9996_CR123","doi-asserted-by":"crossref","unstructured":"Di Micco R, Krizhanovsky V, Baker D, d\u2019Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021;22:75\u201395.","DOI":"10.1038\/s41580-020-00314-w"},{"key":"9996_CR124","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/1873-3468.13498","volume":"593","author":"J Chapman","year":"2019","unstructured":"Chapman J, Fielder E, Passos JF. Mitochondrial dysfunction and cell senescence: deciphering a complex relationship. FEBS Lett. 2019;593:1566\u201379.","journal-title":"FEBS Lett"},{"key":"9996_CR125","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature13193","volume":"509","author":"JM van Deursen","year":"2014","unstructured":"van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509:439\u201346.","journal-title":"Nature"},{"key":"9996_CR126","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/bjc.2016.115","volume":"114","author":"P Lecot","year":"2016","unstructured":"Lecot P, Alimirah F, Desprez P-Y, Campisi J, Wiley C. Context-dependent effects of cellular senescence in cancer development. Br J Cancer. 2016;114:1180\u20134.","journal-title":"Br J Cancer"},{"key":"9996_CR127","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3389\/fcell.2020.00773","volume":"8","author":"HN Wilkinson","year":"2020","unstructured":"Wilkinson HN, Hardman MJ. Senescence in wound repair: emerging strategies to target chronic healing wounds. Front Cell Dev Biol. 2020;8:773.","journal-title":"Front Cell Dev Biol"},{"key":"9996_CR128","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","volume":"3","author":"CD Wiley","year":"2021","unstructured":"Wiley CD, Campisi J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat Metab. 2021;3:1290\u2013301.","journal-title":"Nat Metab"},{"key":"9996_CR129","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.4161\/cc.8.24.10310","volume":"8","author":"MV Blagosklonny","year":"2009","unstructured":"Blagosklonny MV. TOR-driven aging: speeding car without brakes. Cell Cycle. 2009;8:4055\u20139.","journal-title":"Cell Cycle"},{"key":"9996_CR130","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.18632\/aging.100411","volume":"3","author":"MV Blagosklonny","year":"2011","unstructured":"Blagosklonny MV. Hormesis does not make sense except in the light of TOR-driven aging. Aging (Albany NY). 2011;3:1051\u201362.","journal-title":"Aging (Albany NY)"},{"key":"9996_CR131","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00553.2022","author":"CM Dungan","year":"2023","unstructured":"Dungan CM, Wells JM, Murach KA. The life and times of cellular senescence in skeletal muscle: friend or foe for homeostasis and adaptation? Am J Physiol Cell Physiol. 2023. https:\/\/doi.org\/10.1152\/ajpcell.00553.2022.","journal-title":"Am J Physiol Cell Physiol"},{"key":"9996_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Sig Transduct Target Ther. 2023;8:239.","journal-title":"Sig Transduct Target Ther"},{"key":"9996_CR133","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J-P Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"9996_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111548","volume":"198","author":"U Tripathi","year":"2021","unstructured":"Tripathi U, Misra A, Tchkonia T, Kirkland JL. Impact of senescent cell subtypes on tissue dysfunction and repair: importance and research questions. Mech Ageing Dev. 2021;198:111548.","journal-title":"Mech Ageing Dev"},{"key":"9996_CR135","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13314","volume":"20","author":"I Katzir","year":"2021","unstructured":"Katzir I, Adler M, Karin O, Mendelsohn-Cohen N, Mayo A, Alon U. Senescent cells and the incidence of age-related diseases. Aging Cell. 2021;20:e13314.","journal-title":"Aging Cell"},{"key":"9996_CR136","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MNH.0000000000000782","volume":"31","author":"H Tan","year":"2022","unstructured":"Tan H, Xu J, Liu Y. Ageing, cellular senescence and chronic kidney disease: experimental evidence. Curr Opin Nephrol Hypertens. 2022;31:235\u201343.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9996_CR137","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/joim.13775","volume":"295","author":"V Boccardi","year":"2024","unstructured":"Boccardi V, Orr ME, Polidori MC, Ruggiero C, Mecocci P. Focus on senescence: clinical significance and practical applications. J Intern Med. 2024;295:599\u2013619.","journal-title":"J Intern Med"},{"key":"9996_CR138","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","volume":"75","author":"J Campisi","year":"2013","unstructured":"Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685\u2013705.","journal-title":"Annu Rev Physiol"},{"key":"9996_CR139","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","volume":"19","author":"DV Faget","year":"2019","unstructured":"Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19:439\u201353.","journal-title":"Nat Rev Cancer"},{"key":"9996_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111428","volume":"194","author":"D Frasca","year":"2021","unstructured":"Frasca D, Saada YB, Garcia D, Friguet B. Effects of cellular senescence on metabolic pathways in non-immune and immune cells. Mech Ageing Dev. 2021;194:111428.","journal-title":"Mech Ageing Dev"},{"key":"9996_CR141","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"N Herranz","year":"2018","unstructured":"Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018;128:1238\u201346.","journal-title":"J Clin Invest"},{"key":"9996_CR142","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1002\/1878-0261.13269","volume":"16","author":"LD Cassidy","year":"2022","unstructured":"Cassidy LD, Narita M. Autophagy at the intersection of aging, senescence, and cancer. Mol Oncol. 2022;16:3259\u201375.","journal-title":"Mol Oncol"},{"key":"9996_CR143","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.devcel.2021.04.008","volume":"56","author":"Y Lee","year":"2021","unstructured":"Lee Y, Kim J, Kim M-S, Kwon Y, Shin S, Yi H, et al. Coordinate regulation of the senescent state by selective autophagy. Dev Cell. 2021;56:1512-1525.e7.","journal-title":"Dev Cell"},{"key":"9996_CR144","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501:45\u201351.","journal-title":"Nature"},{"key":"9996_CR145","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/febs.16231","volume":"290","author":"T Yasuda","year":"2023","unstructured":"Yasuda T, Baba H, Ishimoto T. Cellular senescence in the tumor microenvironment and context-specific cancer treatment strategies. FEBS J. 2023;290:1290\u2013302.","journal-title":"FEBS J"},{"key":"9996_CR146","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1101\/gad.290635.116","volume":"31","author":"B Ritschka","year":"2017","unstructured":"Ritschka B, Storer M, Mas A, Heinzmann F, Ortells MC, Morton JP, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31:172\u201383.","journal-title":"Genes Dev"},{"key":"9996_CR147","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24:1246\u201356.","journal-title":"Nat Med"},{"key":"9996_CR148","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","volume":"1","author":"NS Gasek","year":"2021","unstructured":"Gasek NS, Kuchel GA, Kirkland JL, Xu M. Strategies for targeting senescent cells in human disease. Nat Aging. 2021;1:870\u20139.","journal-title":"Nat Aging"},{"key":"9996_CR149","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/jtim-2025-0005","volume":"13","author":"TE Fu","year":"2025","unstructured":"Fu TE, Zhou Z. Senescent cells as a target for anti-aging interventions: from senolytics to immune therapies. J Transl Intern Med. 2025;13:33\u201347.","journal-title":"J Transl Intern Med"},{"key":"9996_CR150","doi-asserted-by":"crossref","unstructured":"Romashkan S, Chang H, Hadley EC. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials. Newman AB, editor. The Journals of Gerontology: Series A. 2021;76:1144\u201352.","DOI":"10.1093\/gerona\/glab028"},{"key":"9996_CR151","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad127","volume":"52","author":"MD Witham","year":"2023","unstructured":"Witham MD, Granic A, Miwa S, Passos JF, Richardson GD, Sayer AA. New horizons in cellular senescence for clinicians. Age Ageing. 2023;52:afad127.","journal-title":"Age Ageing"},{"key":"9996_CR152","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/gerona\/glad034","volume":"78","author":"SE Espinoza","year":"2023","unstructured":"Espinoza SE, Khosla S, Baur JA, de Cabo R, Musi N. Drugs targeting mechanisms of aging to delay age-related disease and promote healthspan: proceedings of a National Institute on Aging workshop. J Gerontol A Biol Sci Med Sci. 2023;78:53\u201360.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"9996_CR153","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41556-019-0287-4","volume":"21","author":"T Nacarelli","year":"2019","unstructured":"Nacarelli T, Lau L, Fukumoto T, Zundell J, Fatkhutdinov N, Wu S, et al. NAD+ metabolism governs the proinflammatory senescence-associated secretome. Nat Cell Biol. 2019;21:397\u2013407.","journal-title":"Nat Cell Biol"},{"key":"9996_CR154","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/febs.16361","volume":"290","author":"H Martini","year":"2023","unstructured":"Martini H, Passos JF. Cellular senescence: all roads lead to mitochondria. FEBS J. 2023;290:1186\u2013202.","journal-title":"FEBS J"},{"key":"9996_CR155","doi-asserted-by":"crossref","unstructured":"Freeberg KA, Udovich CAC, Martens CR, Seals DR, Craighead DH. Dietary supplementation with NAD +-boosting compounds in humans: Current knowledge and future directions. J Gerontol A Biol Sci Med Sci. 2023;glad106.","DOI":"10.1093\/gerona\/glad106"},{"key":"9996_CR156","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24:795\u2013806.","journal-title":"Cell Metab"},{"key":"9996_CR157","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002153","author":"G-J Zhao","year":"2023","unstructured":"Zhao G-J, Yang X-Y, Zhang C, Dong W, Dong F-B, Zhang J, et al. Supplementation with nicotinamide riboside attenuates T cell exhaustion and improves survival in sepsis. Shock. 2023. https:\/\/doi.org\/10.1097\/SHK.0000000000002153.","journal-title":"Shock"},{"key":"9996_CR158","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s11357-023-00752-2","volume":"45","author":"AJ Stock","year":"2023","unstructured":"Stock AJ, Ayyar S, Kashyap A, Wang Y, Yanai H, Starost MF, et al. Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo. Geroscience. 2023;45:2213\u201328.","journal-title":"Geroscience"},{"key":"9996_CR159","doi-asserted-by":"crossref","unstructured":"Lapatto HAK, Kuusela M, Heikkinen A, Muniandy M, van der Kolk BW, Gopalakrishnan S, et al. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. Sci Adv. 2023;9:eadd5163.","DOI":"10.1126\/sciadv.add5163"},{"key":"9996_CR160","doi-asserted-by":"publisher","first-page":"E417","DOI":"10.1152\/ajpendo.00242.2023","volume":"326","author":"IDM Gindri","year":"2024","unstructured":"Gindri IDM, Ferrari G, Pinto LPS, Bicca J, Dos Santos IK, Dallacosta D, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024;326:E417\u201327.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9996_CR161","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1038\/s41467-024-49092-5","volume":"15","author":"MM McDermott","year":"2024","unstructured":"McDermott MM, Martens CR, Domanchuk KJ, Zhang D, Peek CB, Criqui MH, et al. Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nat Commun. 2024;15:5046.","journal-title":"Nat Commun"},{"key":"9996_CR162","first-page":"2284","volume":"92","author":"RPR Nanga","year":"2024","unstructured":"Nanga RPR, Wiers CE, Elliott MA, Wilson NE, Liu F, Cao Q, et al. Acute nicotinamide riboside supplementation increases human cerebral NAD+ levels in vivo. Magn Reson Med. 2024;92:2284\u201393.","journal-title":"Magn Reson Med"},{"key":"9996_CR163","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04335-w","author":"J She","year":"2024","unstructured":"She J, Zhang H, Xu H, Li Y-Y, Wu J-C, Han R, et al. Nicotinamide riboside restores nicotinamide adenine dinucleotide levels and alleviates brain injury by inhibiting oxidative stress and neuroinflammation in a mouse model of intracerebral hemorrhage. Mol Neurobiol. 2024. https:\/\/doi.org\/10.1007\/s12035-024-04335-w.","journal-title":"Mol Neurobiol"},{"issue":"25","key":"9996_CR164","first-page":"00070","volume":"S1043\u20132760","author":"C D\u00f6lle","year":"2025","unstructured":"D\u00f6lle C, Tzoulis C. NAD augmentation as a disease-modifying strategy for neurodegeneration. Trends Endocrinol Metab. 2025;S1043\u20132760(25):00070.","journal-title":"Trends Endocrinol Metab"},{"key":"9996_CR165","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40279-022-01772-2","volume":"52","author":"D Campelj","year":"2022","unstructured":"Campelj D, Philp A. NAD+ therapeutics and skeletal muscle adaptation to exercise in humans. Sports Med. 2022;52:91\u20139.","journal-title":"Sports Med"},{"key":"9996_CR166","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi4862","volume":"9","author":"MV Damgaard","year":"2023","unstructured":"Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Sci Adv. 2023;9:eadi4862.","journal-title":"Sci Adv"},{"key":"9996_CR167","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","volume":"25","author":"ME Migaud","year":"2024","unstructured":"Migaud ME, Ziegler M, Baur JA. Regulation of and challenges in targeting NAD+ metabolism. Nat Rev Mol Cell Biol. 2024;25:822\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9996_CR168","doi-asserted-by":"crossref","unstructured":"Zhang J, Poon ET-C, Wong SH-S. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critic Rev Food Sci Nutr. 2025;65(22):4382\u20134400.","DOI":"10.1080\/10408398.2024.2387324"},{"key":"9996_CR169","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13920","volume":"23","author":"CCS Chini","year":"2024","unstructured":"Chini CCS, Cordeiro HS, Tran NLK, Chini EN. NAD metabolism: role in senescence regulation and aging. Aging Cell. 2024;23:e13920.","journal-title":"Aging Cell"},{"key":"9996_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.924299","volume":"13","author":"S Shen","year":"2022","unstructured":"Shen S, Ji C, Wei K. Cellular senescence and regulated cell death of tubular epithelial cells in diabetic kidney disease. Front Endocrinol (Lausanne). 2022;13:924299.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9996_CR171","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/db14-1820","volume":"64","author":"AK Palmer","year":"2015","unstructured":"Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes. 2015;64:2289\u201398.","journal-title":"Diabetes"},{"key":"9996_CR172","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/dom.14503","volume":"23","author":"MN Kim","year":"2021","unstructured":"Kim MN, Moon JH, Cho YM. Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation. Diabetes Obes Metab. 2021;23:2561\u201371.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"9996_CR173","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.molcel.2018.07.036","volume":"71","author":"Y Han","year":"2018","unstructured":"Han Y, Bedarida T, Ding Y, Somba BK, Lu Q, Wang Q, et al. \u0392-hydroxybutyrate prevents vascular senescence through hnRNP A1-mediated upregulation of Oct4. Mol Cell. 2018;71(6):1064-1078.e5.","journal-title":"Mol Cell"},{"key":"9996_CR174","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.kint.2021.06.031","volume":"100","author":"Y Fang","year":"2021","unstructured":"Fang Y, Chen B, Gong AY, Malhotra DK, Gupta R, Dworkin LD, et al. The ketone body \u03b2-hydroxybutyrate mitigates the senescence response of glomerular podocytes to diabetic insults. Kidney Int. 2021;100:1037\u201353.","journal-title":"Kidney Int"},{"key":"9996_CR175","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12746","volume":"17","author":"L Fontana","year":"2018","unstructured":"Fontana L, Mitchell SE, Wang B, Tosti V, Van Vliet T, Veronese N, et al. The effects of graded caloric restriction: XII. comparison of mouse to human impact on cellular senescence in the colon. Aging Cell. 2018;17:e12746.","journal-title":"Aging Cell"},{"key":"9996_CR176","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/NHA-1614","volume":"4","author":"EO List","year":"2016","unstructured":"List EO, Jensen E, Kowalski J, Buchman M, Berryman DE, Kopchick JJ. Diet-induced weight loss is sufficient to reduce senescent cell number in white adipose tissue of weight-cycled mice. Nutr Health Aging. 2016;4:95\u20139.","journal-title":"Nutr Health Aging"},{"key":"9996_CR177","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.mad.2013.11.006","volume":"134","author":"Y-C Ning","year":"2013","unstructured":"Ning Y-C, Cai G-Y, Zhuo L, Gao J-J, Dong D, Cui S, et al. Short-term calorie restriction protects against renal senescence of aged rats by increasing autophagic activity and reducing oxidative damage. Mech Ageing Dev. 2013;134:570\u20139.","journal-title":"Mech Ageing Dev"},{"key":"9996_CR178","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.09.005","volume":"107","author":"W Wang","year":"2018","unstructured":"Wang W, Cai G, Chen X. Dietary restriction delays the secretion of senescence associated secretory phenotype by reducing DNA damage response in the process of renal aging. Exp Gerontol. 2018;107:4\u201310.","journal-title":"Exp Gerontol"},{"key":"9996_CR179","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.trsl.2019.07.005","volume":"213","author":"SR Kim","year":"2019","unstructured":"Kim SR, Jiang K, Ogrodnik M, Chen X, Zhu X-Y, Lohmeier H, et al. Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin. Transl Res. 2019;213:112\u201323.","journal-title":"Transl Res"},{"key":"9996_CR180","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40279-016-0577-y","volume":"47","author":"PJM Pinckaers","year":"2017","unstructured":"Pinckaers PJM, Churchward-Venne TA, Bailey D, van Loon LJC. Ketone bodies and exercise performance: the next magic bullet or merely hype? Sports Med. 2017;47:383\u201391.","journal-title":"Sports Med"},{"key":"9996_CR181","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41514-023-00100-w","volume":"9","author":"M Demaria","year":"2023","unstructured":"Demaria M, Bertozzi B, Veronese N, Spelta F, Cava E, Tosti V, et al. Long-term intensive endurance exercise training is associated to reduced markers of cellular senescence in the colon mucosa of older adults. NPJ Aging. 2023;9:3.","journal-title":"NPJ Aging"},{"key":"9996_CR182","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13415","volume":"20","author":"DA Englund","year":"2021","unstructured":"Englund DA, Sakamoto AE, Fritsche CM, Heeren AA, Zhang X, Kotajarvi BR, et al. Exercise reduces circulating biomarkers of cellular senescence in humans. Aging Cell. 2021;20:e13415.","journal-title":"Aging Cell"},{"key":"9996_CR183","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41574-020-0381-5","volume":"16","author":"F Magkos","year":"2020","unstructured":"Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16:545\u201355.","journal-title":"Nat Rev Endocrinol"},{"key":"9996_CR184","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.2337\/dc22-0886","volume":"45","author":"M Rietz","year":"2022","unstructured":"Rietz M, Lehr A, Mino E, Lang A, Szczerba E, Schiemann T, et al. Physical activity and risk of major diabetes-related complications in individuals with diabetes: a systematic review and meta-analysis of observational studies. Diabetes Care. 2022;45:3101\u201311.","journal-title":"Diabetes Care"},{"key":"9996_CR185","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41569-020-00437-9","volume":"18","author":"PL Valenzuela","year":"2021","unstructured":"Valenzuela PL, Carrera-Bastos P, G\u00e1lvez BG, Ruiz-Hurtado G, Ordovas JM, Ruilope LM, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18:251\u201375.","journal-title":"Nat Rev Cardiol"},{"key":"9996_CR186","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41569-018-0065-1","volume":"15","author":"C Fiuza-Luces","year":"2018","unstructured":"Fiuza-Luces C, Santos-Lozano A, Joyner M, Carrera-Bastos P, Picazo O, Zugaza JL, et al. Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat Rev Cardiol. 2018;15:731\u201343.","journal-title":"Nat Rev Cardiol"},{"key":"9996_CR187","doi-asserted-by":"publisher","unstructured":"Sorriento D, Di Vaia E, Iaccarino G. Physical Exercise: A Novel Tool to Protect Mitochondrial Health. Front Physiol [Internet]. 2021 [cited 2025 Jul 19];12. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fphys.2021.660068\/full","DOI":"10.3389\/fphys.2021.660068\/full"},{"key":"9996_CR188","doi-asserted-by":"publisher","unstructured":"Zhang H, Zhang Y, Zhang J, Jia D. Exercise Alleviates Cardiovascular Diseases by Improving Mitochondrial Homeostasis. JAHA [Internet]. 2024 [cited 2025 Jul 19];13. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/JAHA.124.036555","DOI":"10.1161\/JAHA.124.036555"},{"key":"9996_CR189","unstructured":"Zhou X-H, Luo Y-X, Yao X-Q. Exercise-driven cellular autophagy: A bridge to systematic wellness. Journal of Advanced Research [Internet]. 2025 [cited 2025 Jul 19]; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123224006131"},{"key":"9996_CR190","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","volume":"2","author":"GD Lopaschuk","year":"2023","unstructured":"Lopaschuk GD, Dyck JRB. Ketones and the cardiovascular system. Nat Cardiovasc Res. 2023;2:425\u201337.","journal-title":"Nat Cardiovasc Res"},{"key":"9996_CR191","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cmet.2022.07.014","volume":"34","author":"L Traxler","year":"2022","unstructured":"Traxler L, Herdy JR, Stefanoni D, Eichhorner S, Pelucchi S, Sz\u00fccs A, et al. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer\u2019s disease. Cell Metab. 2022;34:1248-1263.e6.","journal-title":"Cell Metab"},{"key":"9996_CR192","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2020.12.065","volume":"77","author":"SR Yurista","year":"2021","unstructured":"Yurista SR, Chong C-R, Badimon JJ, Kelly DP, de Boer RA, Westenbrink BD. Therapeutic potential of ketone bodies for patients with cardiovascular disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;77:1660\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"9996_CR193","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14562","volume":"24","author":"P Ekanayake","year":"2022","unstructured":"Ekanayake P, Mudaliar S. A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitors. Diabetes Obes Metab. 2022;24:3\u201311.","journal-title":"Diabetes Obes Metab"},{"key":"9996_CR194","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad273","volume":"17","author":"T Weimbs","year":"2024","unstructured":"Weimbs T, Saville J, Kalantar-Zadeh K. Ketogenic metabolic therapy for chronic kidney disease \u2013 the pro part. Clin Kidney J. 2024;17:sfad273.","journal-title":"Clin Kidney J"},{"key":"9996_CR195","doi-asserted-by":"publisher","first-page":"1443781","DOI":"10.3389\/fphys.2024.1443781","volume":"15","author":"V St-Pierre","year":"2024","unstructured":"St-Pierre V, Richard G, Croteau E, Fortier M, Vandenberghe C, Carpentier AC, et al. Cardiorenal ketone metabolism in healthy humans assessed by 11C-acetoacetate PET: effect of D-\u03b2-hydroxybutyrate, a meal, and age. Front Physiol. 2024;15:1443781.","journal-title":"Front Physiol"},{"key":"9996_CR196","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s12276-020-0415-z","volume":"52","author":"Y-M Han","year":"2020","unstructured":"Han Y-M, Ramprasath T, Zou M-H. \u03b2-hydroxybutyrate and its metabolic effects on age-associated pathology. Exp Mol Med. 2020;52:548\u201355.","journal-title":"Exp Mol Med"},{"key":"9996_CR197","first-page":"160","volume":"4","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Wang Q-Q, Lan X-Q, Zhang H-J, Wei D-X. Function and treatment strategies of \u03b2-hydroxybutyrate in aging. Smart Mater Med. 2023;4:160\u201372.","journal-title":"Smart Mater Med"},{"key":"9996_CR198","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado1463","volume":"10","author":"S-J Wei","year":"2024","unstructured":"Wei S-J, Schell JR, Chocron ES, Varmazyad M, Xu G, Chen WH, et al. Ketogenic diet induces p53-dependent cellular senescence in multiple organs. Sci Adv. 2024;10:eado1463.","journal-title":"Sci Adv"},{"key":"9996_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther. 2022;7:11.","journal-title":"Signal Transduct Target Ther"},{"key":"9996_CR200","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad274","volume":"17","author":"S Joshi","year":"2024","unstructured":"Joshi S, Shi R, Patel J. Risks of the ketogenic diet in CKD \u2013 the con part. Clin Kidney J. 2024;17:sfad274.","journal-title":"Clin Kidney J"},{"key":"9996_CR201","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00424-024-02910-7","volume":"476","author":"MLAJ Wie\u00ebrs","year":"2024","unstructured":"Wie\u00ebrs MLAJ, Beynon-Cobb B, Visser WJ, Attaye I. Dietary acid load in health and disease. Pflugers Arch - Eur J Physiol. 2024;476:427\u201343.","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"9996_CR202","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.ackd.2022.03.008","volume":"29","author":"L Frassetto","year":"2022","unstructured":"Frassetto L, Remer T, Banerjee T. Dietary contributions to metabolic acidosis. Adv Chronic Kidney Dis. 2022;29:373\u201380.","journal-title":"Adv Chronic Kidney Dis"},{"key":"9996_CR203","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eplepsyres.2017.07.014","volume":"136","author":"PJ Simm","year":"2017","unstructured":"Simm PJ, Bicknell-Royle J, Lawrie J, Nation J, Draffin K, Stewart KG, et al. The effect of the ketogenic diet on the developing skeleton. Epilepsy Res. 2017;136:62\u20136.","journal-title":"Epilepsy Res"},{"key":"9996_CR204","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fendo.2019.00880","volume":"10","author":"IA Heikura","year":"2019","unstructured":"Heikura IA, Burke LM, Hawley JA, Ross ML, Garvican-Lewis L, Sharma AP, et al. A short-term ketogenic diet impairs markers of bone health in response to exercise. Front Endocrinol (Lausanne). 2019;10:880.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9996_CR205","first-page":"39","volume":"9","author":"P Acharya","year":"2021","unstructured":"Acharya P, Acharya C, Thongprayoon C, Hansrivijit P, Kanduri SR, Kovvuru K, et al. Incidence and characteristics of kidney stones in patients on ketogenic diet: a systematic review and meta-analysis. Dis. 2021;9:39.","journal-title":"Dis"},{"key":"9996_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1287140","volume":"14","author":"Y Peng","year":"2024","unstructured":"Peng Y, Zhong Z, Huang C, Wang W. The effects of popular diets on bone health in the past decade: a narrative review. Front Endocrinol. 2024;14:1287140.","journal-title":"Front Endocrinol"},{"issue":"1","key":"9996_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02874-y","volume":"21","author":"C Patikorn","year":"2023","unstructured":"Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, et al. Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. BMC Med. 2023;21(1):196.","journal-title":"BMC Med"},{"key":"9996_CR208","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39558","volume":"4","author":"C Patikorn","year":"2021","unstructured":"Patikorn C, Roubal K, Veettil SK, Chandran V, Pham T, Lee YY, et al. Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized clinical trials. JAMA Netw Open. 2021;4:e2139558.","journal-title":"JAMA Netw Open"},{"key":"9996_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2023.100495","volume":"14","author":"T Schmidt","year":"2023","unstructured":"Schmidt T, Harmon DM, Kludtke E, Mickow A, Simha V, Kopecky S. Dramatic elevation of LDL cholesterol from ketogenic-dieting: a case series. Am J Prev Cardiol. 2023;14:100495.","journal-title":"Am J Prev Cardiol"},{"key":"9996_CR210","doi-asserted-by":"publisher","DOI":"10.1177\/2042098621989134","volume":"12","author":"R Pelletier","year":"2021","unstructured":"Pelletier R, Ng K, Alkabbani W, Labib Y, Mourad N, Gamble J-M. Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews. Ther Adv Drug Saf. 2021;12:2042098621989134.","journal-title":"Ther Adv Drug Saf"},{"key":"9996_CR211","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcjd.2021.04.006","volume":"46","author":"M Colacci","year":"2022","unstructured":"Colacci M, Fralick J, Odutayo A, Fralick M. Sodium-glucose cotransporter-2 inhibitors and risk of diabetic ketoacidosis among adults with type 2 diabetes: a systematic review and meta-analysis. Can J Diabetes. 2022;46:10-15.e2.","journal-title":"Can J Diabetes"},{"key":"9996_CR212","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1210\/clinem\/dgab274","volume":"106","author":"DS-H Lin","year":"2021","unstructured":"Lin DS-H, Lee J-K, Chen W-J. Clinical adverse events associated with sodium-glucose cotransporter 2 inhibitors: a meta-analysis involving 10 randomized clinical trials and 71 553 individuals. J Clin Endocrinol Metab. 2021;106:2133\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"9996_CR213","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/jcm14010188","volume":"14","author":"AL Mederle","year":"2024","unstructured":"Mederle AL, Dumitrescu P, Borza C, Kundnani NR. Cutaneous adverse drug reactions associated with SGLT2 inhibitors. JCM. 2024;14:188.","journal-title":"JCM"},{"key":"9996_CR214","doi-asserted-by":"publisher","DOI":"10.3945\/cdn.116.000257","volume":"1","author":"C Vandenberghe","year":"2017","unstructured":"Vandenberghe C, St-Pierre V, Pierotti T, Fortier M, Castellano C-A, Cunnane SC. Tricaprylin alone increases plasma ketone response more than coconut oil or other medium-chain triglycerides: an acute crossover study in healthy adults. Curr Dev Nutr. 2017;1:e000257.","journal-title":"Curr Dev Nutr"},{"key":"9996_CR215","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.jada.2005.09.005","volume":"105","author":"N Darmon","year":"2005","unstructured":"Darmon N, Darmon M, Maillot M, Drewnowski A. A nutrient density standard for vegetables and fruits: nutrients per calorie and nutrients per unit cost. J Am Diet Assoc. 2005;105:1881\u20137.","journal-title":"J Am Diet Assoc"},{"key":"9996_CR216","doi-asserted-by":"publisher","DOI":"10.5888\/pcd11.130390","volume":"11","author":"J Di Noia","year":"2014","unstructured":"Di Noia J. Defining powerhouse fruits and vegetables: a nutrient density approach. Prev Chronic Dis. 2014;11:130390.","journal-title":"Prev Chronic Dis"},{"key":"9996_CR217","doi-asserted-by":"crossref","unstructured":"Yahia EM, Garc\u00eda-Sol\u00eds P, Celis MEM. Contribution of Fruits and Vegetables to Human Nutrition and Health. Postharvest Physiology and Biochemistry of Fruits and Vegetables [Internet]. Elsevier; 2019 [cited 2023 Jun 27]. p. 19\u201345. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128132784000026","DOI":"10.1016\/B978-0-12-813278-4.00002-6"},{"key":"9996_CR218","doi-asserted-by":"crossref","unstructured":"De Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. Longo DL, editor. N Engl J Med. 2019;381:2541\u201351.","DOI":"10.1056\/NEJMra1905136"},{"key":"9996_CR219","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1249\/MSS.0000000000002655","volume":"53","author":"LS Deru","year":"2021","unstructured":"Deru LS, Bikman BT, Davidson LE, Tucker LA, Fellingham G, Bartholomew CL, et al. The effects of exercise on \u03b2-hydroxybutyrate concentrations over a 36-h fast: a randomized crossover study. Med Sci Sports Exerc. 2021;53:1987\u201398.","journal-title":"Med Sci Sports Exerc"},{"key":"9996_CR220","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mehy.2018.08.002","volume":"120","author":"L Pruimboom","year":"2018","unstructured":"Pruimboom L, Muskiet FAJ. Intermittent living; the use of ancient challenges as a vaccine against the deleterious effects of modern life - a hypothesis. Med Hypotheses. 2018;120:28\u201342.","journal-title":"Med Hypotheses"},{"key":"9996_CR221","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/nutrit\/nuad071","volume":"82","author":"C D\u00edez-Arroyo","year":"2024","unstructured":"D\u00edez-Arroyo C, Garc\u00eda-Garc\u00eda M, Soto-M\u00e9ndez MJ, Molina-Montes E, Gil-Campos M, Gil \u00c1, et al. Effect of the ketogenic diet as a treatment for refractory epilepsy in children and adolescents: a systematic review of reviews. Nutr Rev. 2024;82:487\u2013502.","journal-title":"Nutr Rev"},{"key":"9996_CR222","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/epi.14404","volume":"59","author":"T Govil-Dalela","year":"2018","unstructured":"Govil-Dalela T, Kumar A, Behen ME, Chugani HT, Juh\u00e1sz C. Evolution of lobar abnormalities of cerebral glucose metabolism in 41 children with drug-resistant epilepsy. Epilepsia. 2018;59:1307\u201315.","journal-title":"Epilepsia"},{"key":"9996_CR223","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3233\/JAD-180202","volume":"64","author":"E Croteau","year":"2018","unstructured":"Croteau E, Castellano C-A, Richard MA, Fortier M, Nugent S, Lepage M, et al. Ketogenic medium chain triglycerides increase brain energy metabolism in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;64:551\u201361.","journal-title":"J Alzheimers Dis"},{"key":"9996_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1123290","volume":"14","author":"JLB Bohnen","year":"2023","unstructured":"Bohnen JLB, Albin RL, Bohnen NI. Ketogenic interventions in mild cognitive impairment, Alzheimer\u2019s disease, and Parkinson\u2019s disease: a systematic review and critical appraisal. Front Neurol. 2023;14:1123290.","journal-title":"Front Neurol"},{"key":"9996_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2024.100306","volume":"28","author":"L Rong","year":"2024","unstructured":"Rong L, Peng Y, Shen Q, Chen K, Fang B, Li W. Effects of ketogenic diet on cognitive function of patients with Alzheimer\u2019s disease: a systematic review and meta-analysis. J Nutr Health Aging. 2024;28:100306.","journal-title":"J Nutr Health Aging"},{"key":"9996_CR226","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","volume":"15","author":"M Fortier","year":"2019","unstructured":"Fortier M, Castellano C-A, Croteau E, Langlois F, Bocti C, St-Pierre V, et al. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimers Dement. 2019;15:625\u201334.","journal-title":"Alzheimers Dement"},{"key":"9996_CR227","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neurobiolaging.2022.04.005","volume":"115","author":"M Roy","year":"2022","unstructured":"Roy M, Edde M, Fortier M, Croteau E, Castellano C-A, St-Pierre V, et al. A ketogenic intervention improves dorsal attention network functional and structural connectivity in mild cognitive impairment. Neurobiol Aging. 2022;115:77\u201387.","journal-title":"Neurobiol Aging"},{"key":"9996_CR228","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuae098","volume":"83","author":"P Krolak-Salmon","year":"2025","unstructured":"Krolak-Salmon P, Swerdlow RH, Mastain T, Dive-Pouletty C, Pooley N, Kisomi M. Efficacy and safety of exogenous ketones in people with mild neurocognitive disorder and Alzheimer\u2019s disease: a systematic literature review. Nutr Rev. 2025;83:e1034\u201348.","journal-title":"Nutr Rev"},{"key":"9996_CR229","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2016.04.012","volume":"100","author":"R Requejo-Aguilar","year":"2016","unstructured":"Requejo-Aguilar R, Bola\u00f1os JP. Mitochondrial control of cell bioenergetics in Parkinson\u2019s disease. Free Radical Biol Med. 2016;100:123\u201337.","journal-title":"Free Radical Biol Med"},{"key":"9996_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.698661","volume":"9","author":"S Nandakumar","year":"2021","unstructured":"Nandakumar S, Rozich E, Buttitta L. Cell cycle re-entry in the nervous system: from polyploidy to neurodegeneration. Front Cell Dev Biol. 2021;9:698661.","journal-title":"Front Cell Dev Biol"},{"key":"9996_CR231","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4103\/1673-5374.360165","volume":"18","author":"R Requejo-Aguilar","year":"2023","unstructured":"Requejo-Aguilar R. Cdk5 and aberrant cell cycle activation at the core of neurodegeneration. Neural Regen Res. 2023;18:1186\u201390.","journal-title":"Neural Regen Res"},{"key":"9996_CR232","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93:1015\u201334.","journal-title":"Neuron"},{"key":"9996_CR233","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2019.10.016","volume":"77","author":"RI Odle","year":"2020","unstructured":"Odle RI, Walker SA, Oxley D, Kidger AM, Balmanno K, Gilley R, et al. An mTORC1-to-CDK1 switch maintains autophagy suppression during Mitosis. Mol Cell. 2020;77:228-240.e7.","journal-title":"Mol Cell"},{"key":"9996_CR234","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Fiesel FC, Springer W. Autophagy in Parkinson\u2019s disease. J Mol Biol. 2020;432:2651\u201372.","journal-title":"J Mol Biol"},{"key":"9996_CR235","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176:11\u201342.","journal-title":"Cell"},{"key":"9996_CR236","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728\u201341.","journal-title":"Cell"},{"key":"9996_CR237","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.envres.2017.07.048","volume":"159","author":"CE Cicero","year":"2017","unstructured":"Cicero CE, Mostile G, Vasta R, Rapisarda V, Signorelli SS, Ferrante M, et al. Metals and neurodegenerative diseases. A systematic review. Environ Res. 2017;159:82\u201394.","journal-title":"Environ Res"},{"key":"9996_CR238","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7389508","volume":"2023","author":"MI Mart\u00ednez-Hern\u00e1ndez","year":"2023","unstructured":"Mart\u00ednez-Hern\u00e1ndez MI, Acosta-Saavedra LC, Hern\u00e1ndez-Kelly LC, Loaeza-Loaeza J, Ortega A. Microglial activation in metal neurotoxicity: impact in neurodegenerative diseases. BioMed Res Int. 2023;2023:7389508.","journal-title":"BioMed Res Int"},{"key":"9996_CR239","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.3390\/molecules25194536","volume":"25","author":"CS Mocanu","year":"2020","unstructured":"Mocanu CS, Jureschi M, Drochioiu G. Aluminium binding to modified Amyloid-\u03b2 peptides: implications for Alzheimer\u2019s disease. Molecules. 2020;25:4536.","journal-title":"Molecules"},{"key":"9996_CR240","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/ADR-210011","volume":"5","author":"MJ Mold","year":"2021","unstructured":"Mold MJ, O\u2019Farrell A, Morris B, Exley C. Aluminum and tau in neurofibrillary tangles in familial Alzheimer\u2019s disease. J Alzheimers Dis Rep. 2021;5:283\u201394.","journal-title":"J Alzheimers Dis Rep"},{"key":"9996_CR241","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-210612","volume":"85","author":"J Lynn","year":"2022","unstructured":"Lynn J, Park M, Ogunwale C, Acquaah-Mensah GK. A tale of two diseases: exploring mechanisms linking Diabetes mellitus with Alzheimer\u2019s disease. J Alzheimers Dis. 2022;85:485\u2013501.","journal-title":"J Alzheimers Dis"},{"key":"9996_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093165","volume":"21","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV. Type 3 diabetes and its role implications in Alzheimer\u2019s disease. Int J Mol Sci. 2020;21:3165.","journal-title":"Int J Mol Sci"},{"key":"9996_CR243","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00702-015-1371-y","volume":"122","author":"L Fr\u00f6lich","year":"2015","unstructured":"Fr\u00f6lich L, M\u00fcller WE, Riederer P. Editorial: Siegfried Hoyer\u2019s concept of Alzheimer pathophysiology. J Neural Transm. 2015;122:495\u20137.","journal-title":"J Neural Transm"},{"key":"9996_CR244","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10522-017-9692-x","volume":"18","author":"A Atlante","year":"2017","unstructured":"Atlante A, de Bari L, Bobba A, Amadoro G. A disease with a sweet tooth: exploring the Warburg effect in Alzheimer\u2019s disease. Biogerontology. 2017;18:301\u201319.","journal-title":"Biogerontology"},{"key":"9996_CR245","doi-asserted-by":"publisher","first-page":"14038","DOI":"10.1038\/s41598-017-14420-x","volume":"7","author":"K-C Sonntag","year":"2017","unstructured":"Sonntag K-C, Ryu W-I, Amirault KM, Healy RA, Siegel AJ, McPhie DL, et al. Late-onset Alzheimer\u2019s disease is associated with inherent changes in bioenergetics profiles. Sci Rep. 2017;7:14038.","journal-title":"Sci Rep"},{"key":"9996_CR246","doi-asserted-by":"crossref","unstructured":"Wong GC-N, Chow KH-M. DNA damage response-associated cell cycle re-entry and neuronal senescence in brain aging and alzheimer\u2019s disease. J Alzheimers Dis. 2023;94(s1):S429-S451.","DOI":"10.3233\/JAD-220203"},{"key":"9996_CR247","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.1007\/s12035-019-1591-5","volume":"56","author":"KNH Nudelman","year":"2019","unstructured":"Nudelman KNH, McDonald BC, Lahiri DK, Saykin AJ. Biological hallmarks of cancer in Alzheimer\u2019s disease. Mol Neurobiol. 2019;56:7173\u201387.","journal-title":"Mol Neurobiol"},{"key":"9996_CR248","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E21-08-0407","volume":"32","author":"J Chernoff","year":"2021","unstructured":"Chernoff J. The two-hit theory hits 50. Mol Biol Cell. 2021;32:rt1.","journal-title":"Mol Biol Cell"},{"key":"9996_CR249","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.redox.2014.08.002","volume":"2","author":"BG Allen","year":"2014","unstructured":"Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, et al. Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism. Redox Biol. 2014;2:963\u201370.","journal-title":"Redox Biol"},{"key":"9996_CR250","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - where do we stand? Mol Metab. 2020;33:102\u201321.","journal-title":"Mol Metab"},{"key":"9996_CR251","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.semcancer.2017.12.011","volume":"56","author":"A Poff","year":"2019","unstructured":"Poff A, Koutnik AP, Egan KM, Sahebjam S, D\u2019Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma. Semin Cancer Biol. 2019;56:135\u201348.","journal-title":"Semin Cancer Biol"},{"key":"9996_CR252","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cimb43020042","volume":"43","author":"WH Talib","year":"2021","unstructured":"Talib WH, Mahmod AI, Kamal A, Rashid HM, Alashqar AMD, Khater S, et al. Ketogenic diet in cancer prevention and therapy: molecular targets and therapeutic opportunities. Curr Issues Mol Biol. 2021;43:558\u201389.","journal-title":"Curr Issues Mol Biol"},{"key":"9996_CR253","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.879205","volume":"12","author":"Y Lan","year":"2022","unstructured":"Lan Y, Jin C, Kumar P, Yu X, Lenahan C, Sheng J. Ketogenic diets and hepatocellular carcinoma. Front Oncol. 2022;12:879205.","journal-title":"Front Oncol"},{"key":"9996_CR254","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.medj.2021.12.008","volume":"3","author":"L Yang","year":"2022","unstructured":"Yang L, TeSlaa T, Ng S, Nofal M, Wang L, Lan T, et al. Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Med. 2022;3:119\u201336.","journal-title":"Med"},{"key":"9996_CR255","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.clnu.2015.01.013","volume":"35","author":"F Bozzetti","year":"2016","unstructured":"Bozzetti F, Zupec-Kania B. Toward a cancer-specific diet. Clin Nutr. 2016;35:1188\u201395.","journal-title":"Clin Nutr"},{"key":"9996_CR256","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.critrevonc.2017.02.016","volume":"112","author":"SF Winter","year":"2017","unstructured":"Winter SF, Loebel F, Dietrich J. Role of ketogenic metabolic therapy in malignant glioma: a systematic review. Crit Rev Oncol Hematol. 2017;112:41\u201358.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9996_CR257","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051473","volume":"12","author":"K Hagihara","year":"2020","unstructured":"Hagihara K, Kajimoto K, Osaga S, Nagai N, Shimosegawa E, Nakata H, et al. Promising effect of a new ketogenic diet regimen in patients with advanced cancer. Nutrients. 2020;12:1473.","journal-title":"Nutrients"},{"key":"9996_CR258","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.594408","volume":"8","author":"J Li","year":"2021","unstructured":"Li J, Zhang H, Dai Z. Cancer treatment with the ketogenic diet: a systematic review and meta-analysis of animal studies. Front Nutr. 2021;8:594408.","journal-title":"Front Nutr"},{"key":"9996_CR259","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-022-04649-6","volume":"605","author":"O Dmitrieva-Posocco","year":"2022","unstructured":"Dmitrieva-Posocco O, Wong AC, Lundgren P, Golos AM, Descamps HC, Dohnalov\u00e1 L, et al. \u0392-hydroxybutyrate suppresses colorectal cancer. Nature. 2022;605:160\u20135.","journal-title":"Nature"},{"key":"9996_CR260","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1080\/10408398.2020.1847030","volume":"62","author":"L Barrea","year":"2022","unstructured":"Barrea L, Caprio M, Tuccinardi D, Moriconi E, Di Renzo L, Muscogiuri G, et al. Could ketogenic diet \u201cstarve\u201d cancer? Emerging evidence. Crit Rev Food Sci Nutr. 2022;62:1800\u201321.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"9996_CR261","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8105735","volume":"2020","author":"Q Tran","year":"2020","unstructured":"Tran Q, Lee H, Kim C, Kong G, Gong N, Kwon SH, et al. Revisiting the Warburg effect: diet-based strategies for cancer prevention. BioMed Res Int. 2020;2020:8105735.","journal-title":"BioMed Res Int"},{"key":"9996_CR262","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00109-022-02226-y","volume":"100","author":"MF Isaac-Lam","year":"2022","unstructured":"Isaac-Lam MF, DeMichael KM. Calorie restriction and breast cancer treatment: a mini-review. J Mol Med (Berl). 2022;100:1095\u2013109.","journal-title":"J Mol Med (Berl)"},{"key":"9996_CR263","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41577-023-00943-0","volume":"24","author":"C Fiuza-Luces","year":"2024","unstructured":"Fiuza-Luces C, Valenzuela PL, G\u00e1lvez BG, Ram\u00edrez M, L\u00f3pez-Soto A, Simpson RJ, et al. The effect of physical exercise on anticancer immunity. Nat Rev Immunol. 2024;24:282\u201393.","journal-title":"Nat Rev Immunol"},{"key":"9996_CR264","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jshs.2024.01.008","volume":"13","author":"A Plaza-Florido","year":"2024","unstructured":"Plaza-Florido A, Lucia A, Radom-Aizik S, Fiuza-Luces C. Anticancer effects of exercise: insights from single-cell analysis. J Sport Health Sci. 2024;13:676\u20138.","journal-title":"J Sport Health Sci"},{"key":"9996_CR265","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.trecan.2022.12.006","volume":"9","author":"O Bla\u017eevit\u0161","year":"2023","unstructured":"Bla\u017eevit\u0161 O, Di Tano M, Longo VD. Fasting and fasting mimicking diets in cancer prevention and therapy. Trends Cancer. 2023;9:212\u201322.","journal-title":"Trends Cancer"},{"key":"9996_CR266","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.cmet.2024.06.014","volume":"36","author":"C Vernieri","year":"2024","unstructured":"Vernieri C, Ligorio F, Tripathy D, Longo VD. Cyclic fasting-mimicking diet in cancer treatment: preclinical and clinical evidence. Cell Metab. 2024;36:1644\u201367.","journal-title":"Cell Metab"},{"key":"9996_CR267","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaccao.2024.01.007","volume":"6","author":"MS Dabour","year":"2024","unstructured":"Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN. The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 2024;6:159\u201382.","journal-title":"JACC CardioOncol"},{"key":"9996_CR268","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-025-04788-3","volume":"95","author":"W Dong","year":"2025","unstructured":"Dong W, Wang Y, Fan S. Potential anticancer effects of sodium-glucose cotransporter protein 2 (SGLT2) inhibitors canagliflozin and dapagliflozin. Cancer Chemother Pharmacol. 2025;95:63.","journal-title":"Cancer Chemother Pharmacol"},{"key":"9996_CR269","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2054935","author":"L Barrea","year":"2022","unstructured":"Barrea L, Caprio M, Watanabe M, Cammarata G, Feraco A, Muscogiuri G, et al. Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence. Crit Rev Food Sci Nutr. 2022. https:\/\/doi.org\/10.1080\/10408398.2022.2054935.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"9996_CR270","doi-asserted-by":"publisher","DOI":"10.1038\/s44324-024-00029-y","volume":"2","author":"K Fulghum","year":"2024","unstructured":"Fulghum K, Salathe SF, Davis X, Thyfault JP, Puchalska P, Crawford PA. Ketone body metabolism and cardiometabolic implications for cognitive health. npj Metab Health Dis. 2024;2:29.","journal-title":"npj Metab Health Dis"},{"key":"9996_CR271","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.123.067971","volume":"149","author":"K Berg-Hansen","year":"2024","unstructured":"Berg-Hansen K, Gopalasingam N, Christensen KH, Ladefoged B, Andersen MJ, Poulsen SH, et al. Cardiovascular effects of oral ketone ester treatment in patients with heart failure with reduced ejection fraction: a randomized, controlled, double-blind trial. Circulation. 2024;149:1474\u201389.","journal-title":"Circulation"},{"key":"9996_CR272","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuae179","author":"T Lv","year":"2025","unstructured":"Lv T, Liu C, Guo S, Wu M, Wang X, Zhang Z, et al. Targeting ketone body metabolism improves cardiac function and hemodynamics in patients with heart failure: a systematic review and meta-analysis. Nutr Rev. 2025. https:\/\/doi.org\/10.1093\/nutrit\/nuae179.","journal-title":"Nutr Rev"},{"key":"9996_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102531","volume":"102","author":"G Rajakumar","year":"2024","unstructured":"Rajakumar G, Cagigas ML, Wang T, Pan AY, Pelaia T, Fuller SJ, et al. Effect of ketogenic diets on insulin-like growth factor (IGF)-1 in humans: a systematic review and meta-analysis. Ageing Res Rev. 2024;102:102531.","journal-title":"Ageing Res Rev"},{"key":"9996_CR274","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Sig Transduct Target Ther. 2023;8:375.","journal-title":"Sig Transduct Target Ther"},{"key":"9996_CR275","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/nbu.12693","volume":"49","author":"B Salido-Bueno","year":"2024","unstructured":"Salido-Bueno B, Gil-Hernandez E, Rueda-Ruzafa L, Gomez-Chica P, Roman P, Cardona D. Effects of ketogenic diets on cancer-related variables: a systematic review and meta-analysis of randomised controlled trials. Nutr Bull. 2024;49:264\u201377.","journal-title":"Nutr Bull"},{"key":"9996_CR276","first-page":"369","volume":"26","author":"WH Talib","year":"2023","unstructured":"Talib WH, Al-Dalaeen A, Mahmod AI. Ketogenic diet in cancer management. Curr Opin Clin Nutr Metab Care. 2023;26:369\u201376.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"9996_CR277","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1573394719666230717160843","volume":"20","author":"H Qin","year":"2024","unstructured":"Qin H, Zhang F, Gao S. Ketogenic diet therapy for glioma: combined effects. CCTR. 2024;20:177\u201387.","journal-title":"CCTR"},{"key":"9996_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2024.112427","volume":"124","author":"CR Neha","year":"2024","unstructured":"Neha CR. Ketogenic diet as a treatment and prevention strategy for cancer: A therapeutic alternative. Nutrition. 2024;124:112427.","journal-title":"Nutrition"},{"key":"9996_CR279","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.clnesp.2024.06.048","volume":"63","author":"IJ Dikeocha","year":"2024","unstructured":"Dikeocha IJ, Wardill HR, Coller JK, Bowen JM. Dietary interventions and tumor response to chemotherapy in breast cancer: a comprehensive review of preclinical and clinical data. Clin Nutr ESPEN. 2024;63:462\u201375.","journal-title":"Clin Nutr ESPEN"},{"key":"9996_CR280","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.immuni.2022.01.004","volume":"55","author":"N Collins","year":"2022","unstructured":"Collins N, Belkaid Y. Control of immunity via nutritional interventions. Immunity. 2022;55:210\u201323.","journal-title":"Immunity"},{"key":"9996_CR281","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cmet.2023.05.001","volume":"35","author":"BJ Jenkins","year":"2023","unstructured":"Jenkins BJ, Blagih J, Ponce-Garcia FM, Canavan M, Gudgeon N, Eastham S, et al. Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity. Cell Metab. 2023;35:1132-1146.e9.","journal-title":"Cell Metab"},{"key":"9996_CR282","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xie Y-Q, Gao M, Zhao Y, Franco F, Wenes M, et al. Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. Nat Immunol. 2021;22:746\u201356.","journal-title":"Nat Immunol"},{"key":"9996_CR283","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/2326-6066.CIR-20-0791","volume":"9","author":"RD Leone","year":"2021","unstructured":"Leone RD, Powell JD. Fueling the revolution: targeting metabolism to enhance immunotherapy. Cancer Immunol Res. 2021;9:255\u201360.","journal-title":"Cancer Immunol Res"},{"key":"9996_CR284","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.923502","volume":"9","author":"S Hirschberger","year":"2022","unstructured":"Hirschberger S, Gellert L, Effinger D, Muenchhoff M, Herrmann M, Briegel J-M, et al. Ketone bodies improve human CD8+ cytotoxic T-cell immune response during COVID-19 infection. Front Med. 2022;9:923502.","journal-title":"Front Med"},{"key":"9996_CR285","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114323","volume":"13","author":"S Hirschberger","year":"2021","unstructured":"Hirschberger S, Strau\u00df G, Effinger D, Marstaller X, Ferstl A, M\u00fcller MB, et al. Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming. EMBO Mol Med. 2021;13:e14323.","journal-title":"EMBO Mol Med"},{"key":"9996_CR286","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.medj.2020.06.008","volume":"1","author":"BJ Stubbs","year":"2020","unstructured":"Stubbs BJ, Koutnik AP, Goldberg EL, Upadhyay V, Turnbaugh PJ, Verdin E, et al. Investigating ketone bodies as immunometabolic countermeasures against respiratory viral infections. Med. 2020;1:43\u201365.","journal-title":"Med"},{"key":"9996_CR287","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/v14030602","volume":"14","author":"CNS Allen","year":"2022","unstructured":"Allen CNS, Arjona SP, Santerre M, Sawaya BE. Hallmarks of metabolic reprogramming and their role in viral pathogenesis. Viruses. 2022;14:602.","journal-title":"Viruses"},{"key":"9996_CR288","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-023-01510-8","volume":"8","author":"P Chen","year":"2023","unstructured":"Chen P, Wu M, He Y, Jiang B, He M-L. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. Sig Transduct Target Ther. 2023;8:237.","journal-title":"Sig Transduct Target Ther"},{"key":"9996_CR289","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042072","volume":"7","author":"S Darekar","year":"2012","unstructured":"Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos G, et al. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS ONE. 2012;7:e42072.","journal-title":"PLoS ONE"},{"key":"9996_CR290","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3389\/fimmu.2019.01533","volume":"10","author":"KA Mayer","year":"2019","unstructured":"Mayer KA, St\u00f6ckl J, Zlabinger GJ, Gualdoni GA. Hijacking the supplies: metabolism as a novel facet of virus-host interaction. Front Immunol. 2019;10:1533.","journal-title":"Front Immunol"},{"key":"9996_CR291","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2020.101386","volume":"11","author":"M Kerstholt","year":"2020","unstructured":"Kerstholt M, Netea MG, Joosten LAB. Borrelia burgdorferi hijacks cellular metabolism of immune cells: consequences for host defense. Ticks Tick Borne Dis. 2020;11:101386.","journal-title":"Ticks Tick Borne Dis"},{"key":"9996_CR292","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881-895.e20.","journal-title":"Cell"},{"key":"9996_CR293","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39049-x","volume":"13","author":"Y L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez Y, Mon\u00e1rrez-Espino J, L\u00f3pez DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. The plasma metabolome of long COVID patients two years after infection. Sci Rep. 2023;13:12420.","journal-title":"Sci Rep"},{"key":"9996_CR294","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656797","volume":"12","author":"M Ruiz-Pablos","year":"2021","unstructured":"Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front Immunol. 2021;12:656797.","journal-title":"Front Immunol"},{"key":"9996_CR295","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/s-0031-1287654","volume":"31","author":"AL Komaroff","year":"2011","unstructured":"Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol. 2011;31:325\u201337.","journal-title":"Semin Neurol"},{"key":"9996_CR296","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89376","volume":"1","author":"\u00d8 Fluge","year":"2016","unstructured":"Fluge \u00d8, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome. JCI Insight. 2016;1:e89376.","journal-title":"JCI Insight"},{"key":"9996_CR297","doi-asserted-by":"crossref","first-page":"E5472","DOI":"10.1073\/pnas.1605669113","volume":"113","author":"RK Naviaux","year":"2016","unstructured":"Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2016;113:E5472-5480.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9996_CR298","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.biochi.2020.11.010","volume":"180","author":"P Icard","year":"2021","unstructured":"Icard P, Lincet H, Wu Z, Coquerel A, Forgez P, Alifano M, et al. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 2021;180:169\u201377.","journal-title":"Biochimie"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09996-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09996-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09996-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:08:26Z","timestamp":1775034506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09996-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":298,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["9996"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09996-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"18 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author 2 (Marcel H.A. Muskiet) has acted as a consultant or speaker and has received honoraria from AstraZeneca, Eli Lilly, and Novo Nordisk. The remaining authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}